跳至主要内容
临床试验/IRCT20110510006431N3
IRCT20110510006431N3尚未招募3 期

The effect of probiotic supplementation on glycemic control, cardiometabolic risk factors, and endothelial function in overweight and obese subjects with pre-diabetes

Semnan University of Medical Sciences0 个研究点目标入组 85 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
All

入选标准

  • Pre-diabetes diagnosis within the last 12 months
  • Age between 35-65
  • 25<BMI<40 kg/m2

排除标准

  • Type 1 and 2 diabetes
  • People under treatment with any specific drug protocol including Metformin, Aspirin, OCPs or HRTs, immunosuppressives, and Corticosteroids
  • People treated with antibiotics over the past three months
  • People with digestive disorders, cardiovascular diseases, endocrine disorders, kidney dysfunction and malignancies
  • Pregnant and lactating women, or those planning to become pregnant within the next 12 weeks
  • Smokers, consumers of addictive drugs and alcohol
  • Regular consumption of probiotic foods, or prebiotic and probiotic supplements over the past three months
  • People with major changes in weight, diet and lifestyle over the past three months

研究者

发起方
Semnan University of Medical Sciences

相似试验